Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2022-03-07 02:49:01 UTC |
---|
HMDB ID | HMDB0000365 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Epiandrosterone |
---|
Description | Epiandrosterone is a naturally occurring steroid synthesized in the adrenal cortex, gonads, brain, and gastrointestinal tract. It is less active than androsterone and excreted in small amounts in normal human urine. Epiandrosterone is a metabolite of the most abundant adrenal androgenic steroid dehydroepiandrosterone (DHEA) in young adult humans, but is not completely inactive and is considered an effector as well. Epiandrosterone is a precursor or substrate for cytochrome P450 species and enzymes (EC 1.14.13.100, 25-hydroxycholesterol 7alpha-hydroxylase) that produce 7alpha- and 7beta-hydroxylated metabolites in the human brain and other organs. These 7-hydroxylated derivatives exert anti-glucocorticoid and neuroprotective effects (PMID: 17017935 , 12475725 , 15650074 , 15784286 ). |
---|
Structure | [H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2C[C@@H](O)CC[C@]12C InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-16,20H,3-11H2,1-2H3/t12?,13-,14-,15-,16-,18-,19-/m0/s1 |
---|
Synonyms | Value | Source |
---|
3-Epiandrosterone | HMDB | 3b-Androsterone | HMDB | 3b-Hydroxy-17-oxo-5a-androstane | HMDB | 3b-Hydroxy-5a-androstan-17-one | HMDB | 3b-Hydroxy-5a-androstane-17-one | HMDB | 3b-Hydroxyandrostan-17-one | HMDB | 3b-Hydroxyetioallocholan-17-one | HMDB | 3b-OH-5a-Androstane-17-one | HMDB | 5a-Androstan-3b-ol-17-one | HMDB | 5a-Androstane-3b-ol-17-one | HMDB | D-Epiandrosterone | HMDB | Epi-andosterone | HMDB | Epi-androsterone | HMDB | Iso-androsterone | HMDB | Isoandrosterone | HMDB | trans-Androsterone | HMDB | (3Β,5α)-3-hydroxyandrostan-17-one | HMDB | 3Β-androsterone | HMDB | 3Β-hydroxy-17-oxo-5α-androstane | HMDB | 3Β-hydroxy-5α-androstan-17-one | HMDB | 3Β-hydroxy-5α-androstane-17-one | HMDB | 3Β-hydroxyandrostan-17-one | HMDB | 3Β-hydroxyetioallocholan-17-one | HMDB | 3Β-OH-5α-androstane-17-one | HMDB | 5Α-androstan-17-one-3β-ol | HMDB | 5Α-androstan-3β-ol-17-one | HMDB | 5Α-androstane-3β-ol-17-one | HMDB | (3beta,5alpha)-3-Hydroxyandrostan-17-one | HMDB | 3beta-Androsterone | HMDB | 3beta-Hydroxy-17-oxo-5alpha-androstane | HMDB | 3beta-Hydroxy-5alpha-androstan-17-one | HMDB | 3beta-Hydroxy-5alpha-androstane-17-one | HMDB | 3beta-Hydroxyandrostan-17-one | HMDB | 3beta-Hydroxyetioallocholan-17-one | HMDB | 3beta-OH-5alpha-Androstane-17-one | HMDB | 5alpha-Androstan-17-one-3beta-ol | HMDB | 5alpha-Androstan-3beta-ol-17-one | HMDB | 5alpha-Androstane-3beta-ol-17-one | HMDB |
|
---|
Chemical Formula | C19H30O2 |
---|
Average Molecular Weight | 290.4403 |
---|
Monoisotopic Molecular Weight | 290.224580204 |
---|
IUPAC Name | (1S,2S,5S,10R,11S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-one |
---|
Traditional Name | (1S,2S,5S,10R,11S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-one |
---|
CAS Registry Number | 481-29-8 |
---|
SMILES | [H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2C[C@@H](O)CC[C@]12C |
---|
InChI Identifier | InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-16,20H,3-11H2,1-2H3/t12?,13-,14-,15-,16-,18-,19-/m0/s1 |
---|
InChI Key | QGXBDMJGAMFCBF-QRIARFFBSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Androstane steroids |
---|
Direct Parent | Androgens and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Androgen-skeleton
- 3-hydroxysteroid
- 3-beta-hydroxysteroid
- Oxosteroid
- 17-oxosteroid
- Hydroxysteroid
- Cyclic alcohol
- Secondary alcohol
- Ketone
- Organic oxygen compound
- Organooxygen compound
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Alcohol
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 178 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.02 mg/mL at 23 °C | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Epiandrosterone,1TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CCC4C[C@@H](O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CCC2=O | 2578.5 | Semi standard non polar | 33892256 | Epiandrosterone,1TMS,isomer #2 | C[C@]12CC[C@H]3[C@@H](CCC4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2O[Si](C)(C)C | 2579.0 | Semi standard non polar | 33892256 | Epiandrosterone,2TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CCC4C[C@@H](O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CC=C2O[Si](C)(C)C | 2602.6 | Semi standard non polar | 33892256 | Epiandrosterone,2TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CCC4C[C@@H](O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CC=C2O[Si](C)(C)C | 2511.5 | Standard non polar | 33892256 | Epiandrosterone,2TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CCC4C[C@@H](O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CC=C2O[Si](C)(C)C | 2920.4 | Standard polar | 33892256 | Epiandrosterone,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)O[C@H]1CC[C@@]2(C)C(CC[C@H]3[C@@H]4CCC(=O)[C@@]4(C)CC[C@@H]32)C1 | 2818.4 | Semi standard non polar | 33892256 | Epiandrosterone,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC[C@H]2[C@@H]3CCC4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C | 2849.6 | Semi standard non polar | 33892256 | Epiandrosterone,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC[C@H]2[C@@H]3CCC4C[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3134.5 | Semi standard non polar | 33892256 | Epiandrosterone,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC[C@H]2[C@@H]3CCC4C[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 2771.5 | Standard non polar | 33892256 | Epiandrosterone,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC[C@H]2[C@@H]3CCC4C[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3167.0 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Epiandrosterone GC-MS (Non-derivatized) - 70eV, Positive | splash10-03ea-0390000000-17f2f9f14aa5e282a19a | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epiandrosterone GC-MS (1 TMS) - 70eV, Positive | splash10-0f7k-1139000000-2bff067a4137502d6ea7 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epiandrosterone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epiandrosterone GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epiandrosterone GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epiandrosterone GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Epiandrosterone Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-05fr-0190000000-b665b61b3fc9060b35b5 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Epiandrosterone Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-0a4i-4900000000-e43c3bdb0c139ec15f8b | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Epiandrosterone Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-05mo-9300000000-c77bd97ae174005bf348 | 2012-07-24 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Epiandrosterone 10V, Positive-QTOF | splash10-00dl-0090000000-fb385ad40b5d4ae1a6d9 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Epiandrosterone 20V, Positive-QTOF | splash10-00dm-0290000000-6287ec557af150ef07fe | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Epiandrosterone 40V, Positive-QTOF | splash10-000t-3690000000-da6f3211b1e397dcf1ae | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Epiandrosterone 10V, Negative-QTOF | splash10-000i-0090000000-03f14a475acfab5558d6 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Epiandrosterone 20V, Negative-QTOF | splash10-000i-0090000000-5e4902f7af7820145954 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Epiandrosterone 40V, Negative-QTOF | splash10-06xx-2090000000-97cca29f0df7b3cc3714 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Epiandrosterone 10V, Positive-QTOF | splash10-0006-0090000000-afb176951034ef62419f | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Epiandrosterone 20V, Positive-QTOF | splash10-052e-0930000000-1ed776267953f7acda8a | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Epiandrosterone 40V, Positive-QTOF | splash10-0a4j-2900000000-1ba60805778f2942bfd7 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Epiandrosterone 10V, Negative-QTOF | splash10-000i-0090000000-c8c452fd99c6bb4f3631 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Epiandrosterone 20V, Negative-QTOF | splash10-000i-0090000000-c8c452fd99c6bb4f3631 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Epiandrosterone 40V, Negative-QTOF | splash10-000i-0090000000-00c0e7de4e528b98df5c | 2021-09-23 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
|
---|
Disease References | Schizophrenia |
---|
- Bicikova M, Hill M, Ripova D, Mohr P, Hampl R: Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia. J Steroid Biochem Mol Biol. 2013 Jan;133:77-83. doi: 10.1016/j.jsbmb.2012.08.009. Epub 2012 Aug 24. [PubMed:22944140 ]
| Colorectal cancer |
---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
|
|
---|
General References | - Mitamura K, Setaka M, Shimada K, Honma S, Namiki M, Koh E, Mizokami A: Determination of sulfates of androsterone and epiandrosterone in human serum using isotope diluted liquid chromatography-electrospray ionization-mass spectrometry. Biomed Chromatogr. 2005 Dec;19(10):796-801. [PubMed:15954157 ]
- Chalbot S, Morfin R: Human liver S9 fractions: metabolism of dehydroepiandrosterone, epiandrosterone, and related 7-hydroxylated derivatives. Drug Metab Dispos. 2005 Apr;33(4):563-9. Epub 2005 Jan 13. [PubMed:15650074 ]
- Johnson MD, Bebb RA, Sirrs SM: Uses of DHEA in aging and other disease states. Ageing Res Rev. 2002 Feb;1(1):29-41. [PubMed:12039447 ]
- Norman RJ, Maharaj C, Adhikari M, Joubert SM: Adrenal sensitivity to adrenocorticotrophin in twin neonates--effect of birth order and growth retardation. S Afr Med J. 1984 Jul 21;66(3):90-2. [PubMed:6330917 ]
- Hungerford NL, Sortais B, Smart CG, McKinney AR, Ridley DD, Stenhouse AM, Suann CJ, Munn KJ, Sillence MN, McLeod MD: Analysis of anabolic steroids in the horse: development of a generic ELISA for the screening of 17alpha-alkyl anabolic steroid metabolites. J Steroid Biochem Mol Biol. 2005 Aug;96(3-4):317-34. [PubMed:16040239 ]
- Thijssen JH, Daroszewski J, Milewicz A, Blankenstein MA: Local aromatase activity in human breast tissues. J Steroid Biochem Mol Biol. 1993 Mar;44(4-6):577-82. [PubMed:8476769 ]
- Matsuzaki Y, Honda A: Dehydroepiandrosterone and its derivatives: potentially novel anti-proliferative and chemopreventive agents. Curr Pharm Des. 2006;12(26):3411-21. [PubMed:17017935 ]
- Yoshida S, Honda A, Matsuzaki Y, Fukushima S, Tanaka N, Takagiwa A, Fujimoto Y, Miyazaki H, Salen G: Anti-proliferative action of endogenous dehydroepiandrosterone metabolites on human cancer cell lines. Steroids. 2003 Jan;68(1):73-83. [PubMed:12475725 ]
- Chalbot S, Morfin R: Neurosteroids: metabolism in human intestine microsomes. Steroids. 2005 Apr;70(4):319-26. [PubMed:15784286 ]
|
---|